{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:14:50Z","timestamp":1778868890529,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41401-019-0269-x","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T12:03:04Z","timestamp":1561723384000},"page":"1364-1372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Structure-based design of a hyperthermostable AgUricase for hyperuricemia and gout therapy"],"prefix":"10.1038","volume":"40","author":[{"given":"Yi","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Edward","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Eric","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"269_CR1","doi-asserted-by":"crossref","unstructured":"Nuki G. Uricase therapy of gout. In Gout and Other Crystal Arthropathies. Elsevier Inc.; 2012. 174\u201386.","DOI":"10.1016\/B978-1-4377-2864-4.10014-4"},{"key":"269_CR2","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1073\/pnas.1320393111","volume":"111","author":"JT Kratzer","year":"2014","unstructured":"Kratzer JT, Lanaspa MA, Murphy MN, Cicerchi C, Graves CL, Tipton PA, et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proc Natl Acad Sci U S A. 2014;111:3763\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"269_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-015-0495-2","volume":"17","author":"AM Abeles","year":"2015","unstructured":"Abeles AM. Hyperuricemia, gout, and cardiovascular disease: an update. Curr Rheumatol Rep. 2015;17:13.","journal-title":"Curr Rheumatol Rep"},{"key":"269_CR4","doi-asserted-by":"publisher","first-page":"e0167935","DOI":"10.1371\/journal.pone.0167935","volume":"11","author":"AC Nyborg","year":"2016","unstructured":"Nyborg AC, Ward C, Zacco A, Chacko B, Grinberg L, Geoghegan JC, et al. A therapeutic uricase with reduced immunogenicity risk and improved development properties. PLoS One. 2016;11:e0167935.","journal-title":"PLoS ONE"},{"key":"269_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/jps.23018","volume":"101","author":"W Jiskoot","year":"2012","unstructured":"Jiskoot W, Randolph TW, Volkin DB, Middaugh CR, Schoneich C, Winter G, et al. Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci. 2012;101:946\u201354.","journal-title":"J Pharm Sci"},{"key":"269_CR6","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.biochem.5b01119","volume":"55","author":"T Hibi","year":"2016","unstructured":"Hibi T, Kume A, Kawamura A, Itoh T, Fukada H, Nishiya Y. Hyperstabilization of tetrameric Bacillus sp. TB-90 urate oxidase by introducing disulfide bonds through structural plasticity. Biochemistry. 2016;55:724\u201332.","journal-title":"Biochemistry"},{"key":"269_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jbiotec.2004.03.026","volume":"113","author":"VG Eijsink","year":"2004","unstructured":"Eijsink VG, Bjork A, Gaseidnes S, Sirevag R, Synstad B, van den Burg B, et al. Rational engineering of enzyme stability. J Biotechnol. 2004;113:105\u201320.","journal-title":"J Biotechnol"},{"key":"269_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1359-6446(03)02610-2","volume":"8","author":"SA Marshall","year":"2003","unstructured":"Marshall SA, Lazar GA, Chirino AJ, Desjarlais JR. Rational design and engineering of therapeutic proteins. Drug Discov Today. 2003;8:212\u201321.","journal-title":"Drug Discov Today"},{"key":"269_CR9","doi-asserted-by":"publisher","first-page":"E1269","DOI":"10.3390\/ijms20061269","volume":"20","author":"S Yainoy","year":"2019","unstructured":"Yainoy S, Phuadraksa T, Wichit S, Sompoppokakul M, Songtawee N, Prachayasittikul V, et al. Production and characterization of recombinant wild type uricase from indonesian coelacanth (L. menadoensis) and improvement of its thermostability by in silico rational design and disulphide bridges engineering. Int J Mol Sci. 2019;20:E1269.","journal-title":"Int J Mol Sci"},{"key":"269_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","volume":"77","author":"HoSN HHD","year":"1989","unstructured":"Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77:51\u20139.","journal-title":"Gene"},{"key":"269_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/aps.2016.69","volume":"37","author":"P Liu","year":"2016","unstructured":"Liu P, Jia MZ, Zhou XE, De Waal PW, Dickson BM, Liu B, et al. The structural basis of the dominant negative phenotype of the Galphai1beta1gamma2 G203A\/A326S heterotrimer. Acta Pharmacol Sin. 2016;37:1259\u201372.","journal-title":"Acta Pharm Sin"},{"key":"269_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/09298665113206660118","volume":"21","author":"Y Shi","year":"2014","unstructured":"Shi Y, Zheng D, Xie J, Zhang Q, Zhang H. Thermal stability of thermoanaerobacter tengcongensis ribosome recycling factor. Protein Pept Lett. 2014;21:285\u201391.","journal-title":"Protein Pept Lett"},{"key":"269_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307\u201326.","journal-title":"Methods Enzymol"},{"key":"269_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40:658\u201374.","journal-title":"J Appl Crystallogr"},{"key":"269_CR15","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60:2126\u201332.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"269_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66:213\u201321.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"269_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011;67:235\u201342.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"269_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1006\/abbi.2000.2088","volume":"384","author":"KA Pikal-Cleland","year":"2000","unstructured":"Pikal-Cleland KA, Rodr\u00edguez-Hornedo N, Amidon GL, Carpenter JF. Protein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric \u03b2-galactosidase. Arch Biochem Biophys. 2000;384:398\u2013406.","journal-title":"Arch Biochem Biophys"},{"key":"269_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1050-3862(99)00041-8","volume":"16","author":"Gonz\u00e1lez Mn","year":"1999","unstructured":"Mn Gonz\u00e1lez, Argara\u00f1a CE, Fidelio GD. Extremely high thermal stability of streptavidin and avidin upon biotin binding. Biomol Eng. 1999;16:67\u201372.","journal-title":"Biomol Eng"},{"key":"269_CR20","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1021\/bi000975w","volume":"39","author":"BI Kurganov","year":"2000","unstructured":"Kurganov BI, Kornilaev BA, Chebotareva NA, Malikov VP, Orlov VN, Lyubarev AE, et al. Dissociative mechanism of thermal denaturation of rabbit skeletal muscle glycogen phosphorylase b. Biochemistry. 2000;39:13144\u201352.","journal-title":"Biochemistry"},{"key":"269_CR21","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1021\/bi982828s","volume":"38","author":"GB Reddy","year":"1999","unstructured":"Reddy GB, Bharadwaj S, Surolia A. Thermal stability and mode of oligomerization of the tetrameric peanut agglutinin:\u2009a differential scanning calorimetry study. Biochemistry. 1999;38:4464\u201370.","journal-title":"Biochemistry"},{"key":"269_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0301-4622(94)00150-I","volume":"54","author":"A Bayol","year":"1995","unstructured":"Bayol A, Dupin P, Boe JF, Claudy P, L\u00e9toff\u00e9 JM. Study of pH and temperature-induced transitions in urate oxidase (Uox-EC1.7.3.3) by microcalorimetry (DSC), size exclusion chromatography (SEC) and enzymatic activity experiments. Biophys Chem. 1995;54:229\u201335.","journal-title":"Biophys Chem"},{"key":"269_CR23","first-page":"295","volume":"9","author":"AA Rastegari","year":"2017","unstructured":"Rastegari AA, Buzari B, Bordbar AK. Thermal stability of pepsin: a predictive thermodynamic model of a multi-domain protein. Biochem Biophys Rep. 2017;9:295\u2013301.","journal-title":"Biochem Biophys Rep"},{"key":"269_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1359-0278(96)00029-6","volume":"1","author":"V Mu\u00f1oz","year":"1996","unstructured":"Mu\u00f1oz V, Cronet P, L\u00f3pez-Hern\u00e9ndez E, Serrano L. Analysis of the effect of local interactions on protein stability. Fold Des. 1996;1:167\u201378.","journal-title":"Fold Des"},{"key":"269_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jbiotec.2006.07.005","volume":"127","author":"M-Y Jeong","year":"2007","unstructured":"Jeong MY, Kim S, Yun CW, Choi YJ, Cho SG. Engineering a de novo internal disulfide bridge to improve the thermal stability of xylanase from Bacillus stearothermophilus No. 236. J Biotechnol. 2007;127:300\u20139.","journal-title":"J Biotechnol"},{"key":"269_CR26","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1074\/jbc.M210721200","volume":"278","author":"HR Nordlund","year":"2003","unstructured":"Nordlund HR, Laitinen OH, Uotila ST, Nyholm T, Hytonen VP, Slotte JP, et al. Enhancing the thermal stability of avidin. Introduction of disulfide bridges between subunit interfaces. J Biol Chem. 2003;278:2479\u201383.","journal-title":"J Biol Chem"},{"key":"269_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.enzmictec.2009.08.009","volume":"45","author":"R Fernandez-Lafuente","year":"2009","unstructured":"Fernandez-Lafuente R. Stabilization of multimeric enzymes: strategies to prevent subunit dissociation. Enzyme Microbiol Technol. 2009;45:405\u201318.","journal-title":"Enzyme Microbiol Technol"},{"key":"269_CR28","doi-asserted-by":"crossref","unstructured":"Donovan JW,\u00a0Beardslee RA. Heat stabilization produced by protein-protein association. A differential scanning calorimetric study of the heat denaturation of the trypsin-soybean trypsin inhibitor and trypsin-ovomucoid complexes. J Biol Chem. 1975;250:1966\u201371.","DOI":"10.1016\/S0021-9258(19)41670-0"},{"key":"269_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bpc.2008.12.005","volume":"141","author":"P Pecher","year":"2009","unstructured":"Pecher P, Arnold U. The effect of additional disulfide bonds on the stability and folding of ribonuclease A. Biophys Chem. 2009;141:21\u20138.","journal-title":"Biophys Chem"},{"key":"269_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1359-0278(97)00007-2","volume":"2","author":"AD Nagi","year":"1997","unstructured":"Nagi AD, Regan L. An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold Des. 1997;2:67\u201375.","journal-title":"Fold Des"},{"key":"269_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(10)60665-4","volume":"377","author":"CM Burns","year":"2011","unstructured":"Burns CM, Wortmann RL. Gout therapeutics: new drugs for an old disease. Lancet. 2011;377:165\u201377.","journal-title":"Lancet"},{"key":"269_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ndt\/gfh629","volume":"20","author":"B Vogt","year":"2005","unstructured":"Vogt B. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol Dial Transpl. 2005;20:431\u20133.","journal-title":"Nephrol Dial Transpl"},{"key":"269_CR33","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1200\/JCO.2003.04.115","volume":"21","author":"B Coiffier","year":"2003","unstructured":"Coiffier B, Mounier N, Bologna S, Ferme C, Tilly H, Sonet A, et al. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin\u2019s lymphoma: results of the GRAAL1 (Groupe d\u2019Etude des Lymphomes de l\u2019Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J Clin Oncol. 2003;21:4402\u20136.","journal-title":"J Clin Oncol"},{"key":"269_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrd3349","volume":"10","author":"N Schlesinger","year":"2010","unstructured":"Schlesinger N, Yasothan U, Kirkpatrick P. Pegloticase. Nat Rev Drug Discov. 2010;10:17.","journal-title":"Nat Rev Drug Discov"},{"key":"269_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/jama.2011.1617","volume":"306","author":"JS Sundy","year":"2011","unstructured":"Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: Two randomized controlled trials. JAMA. 2011;306:711\u201320.","journal-title":"JAMA"},{"key":"269_CR36","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/art.23810","volume":"58","author":"JS Sundy","year":"2008","unstructured":"Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, et al. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. Arthritis Rheum. 2008;58:2882\u201391.","journal-title":"Arthritis Rheum"},{"key":"269_CR37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1136\/annrheumdis-2012-201795","volume":"72","author":"MA Becker","year":"2013","unstructured":"Becker MA, Baraf HS, Yood RA, Dillon A, Vazquez-Mellado J, Ottery FD, et al. Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Ann Rheum Dis. 2013;72:1469\u201374.","journal-title":"Ann Rheum Dis"},{"key":"269_CR38","doi-asserted-by":"crossref","unstructured":"Mandell BF. Clinical manifestations of hyperuricemia and gout. Cleve Clin J Med. 2008;75:S5\u20138.","DOI":"10.3949\/ccjm.75.Suppl_5.S5"},{"key":"269_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/protein\/gzx056","volume":"30","author":"L Tao","year":"2017","unstructured":"Tao L, Li D, Li Y, Shi X, Wang J, Rao C, et al. Designing a mutant Candida uricase with improved polymerization state and enzymatic activity. Protein Eng Des Sel. 2017;30:753\u20139.","journal-title":"Protein Eng Des Sel"},{"key":"269_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.autrev.2015.02.007","volume":"14","author":"M Deehan","year":"2015","unstructured":"Deehan M, Garces S, Kramer D, Baker MP, Rat D, Roettger Y, et al. Managing unwanted immunogenicity of biologicals. Autoimmun Rev. 2015;14:569\u201374.","journal-title":"Autoimmun Rev"},{"key":"269_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1208\/s12248-012-9340-y","volume":"14","author":"N Chirmule","year":"2012","unstructured":"Chirmule N, Jawa V, Meibohm B. Immunogenicity to therapeutic proteins: impact on PK\/PD and efficacy. AAPS J. 2012;14:296\u2013302.","journal-title":"AAPS J"},{"key":"269_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.biologicals.2015.06.004","volume":"43","author":"M Wadhwa","year":"2015","unstructured":"Wadhwa M, Knezevic I, Kang HN, Thorpe R. Immunogenicity assessment of biotherapeutic products: an overview of assays and their utility. Biologicals. 2015;43:298\u2013306.","journal-title":"Biologicals"},{"key":"269_CR43","doi-asserted-by":"publisher","first-page":"1298473","DOI":"10.1155\/2016\/1298473","volume":"2016","author":"A Kuriakose","year":"2016","unstructured":"Kuriakose A, Chirmule N, Nair P. Immunogenicity of biotherapeutics: causes and association with posttranslational modifications. J Immunol Res. 2016;2016:1298473.","journal-title":"J Immunol Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0269-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:09Z","timestamp":1684616529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0269-x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}